metformin has been researched along with CJD (Creutzfeldt-Jakob Disease) in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binyamin, O | 1 |
| Frid, K | 1 |
| Keller, G | 1 |
| Saada, A | 1 |
| Gabizon, R | 1 |
1 other study available for metformin and CJD (Creutzfeldt-Jakob Disease)
| Article | Year |
|---|---|
Comparing anti-aging hallmark activities of Metformin and Nano-PSO in a mouse model of genetic Creutzfeldt-Jakob Disease.
Topics: Adenylate Kinase; Animals; Antioxidants; Creutzfeldt-Jakob Syndrome; Disease Models, Animal; Electro | 2022 |